By Philipp Ritt, PhD, Torsten Kuwert, MD, Clinic of Nuclear Medicine, University Hospital Erlangen, Germany, and Partha Ghosh, MD, Siemens Healthineers, Hoffman Estates, IL, USA
Absolute quantification of 131I uptake in thyroid carcinoma metastases using xSPECT Quant for absorbed dose prediction
2020-06-18
An 82-year-old female with a history of thyroid cancer presented with lesions on a chest CT regarded as suspicious for metastases. The patient underwent a diagnostic 131I scintigraphy performed on a Symbia IntevoTM SPECT/CT scanner. The case highlights the use of xSPECT Quant-based measurement to guide large-dose 131I therapy decisions.
xSPECT Quant, thyroid carcinoma metastasis, i 131 thyroid